HRTX
0.30 USD
+0.00%
Today
+0.00%
1D
Market is closed
Sun
Closed
Mon
4:30 PM ~ 10:59 PM
Tue
4:30 PM ~ 10:59 PM
Wed
4:30 PM ~ 10:59 PM
Thu
4:30 PM ~ 10:59 PM
Fri
4:30 PM ~ 10:59 PM
Sat
Closed
Information
Name
Heron Therapeutics
Currency
USD
Market Cap
54.05M
Avg Daily Volume
2.48M
52 Week High
1.58 USD
52 Week Low
0.26 USD
Trading Hours
See hours
Business Summary
Heron Therapeutics, Inc., a commercial-stage biotechnology company, engages in developing and commercializing therapeutic that enhances medical care. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acute and delayed nausea and vomiting associated with moderately emetogenic chemotherapy, or anthracycline and cyclophosphamide combination chemotherapy regimens; and CINVANTI, an intravenous formulation of aprepitant, a substance P/neurokinin-1 receptor antagonist for the prevention of acute and delayed nausea and vomiting associated with highly emetogenic cancer chemotherapy, as well as nausea and vomiting associated with moderately emetogenic cancer chemotherapy. The company is also developing ZYNRELEF, a dual-acting local anesthetic that delivers a fixed-dose combination of the local anesthetic bupivacaine and a low dose of the nonsteroidal anti-inflammatory drug meloxicam; and APONVIE, an intravenous formulation of a substance P/neurokinin-1 receptor antagonist indicated for the prevention of postoperative nausea and vomiting in adults. Heron Therapeutics, Inc. was formerly known as A.P. Pharma, Inc. and changed its name to Heron Therapeutics, Inc. in January 2014. The company was founded in 1983 and is headquartered in Cary, North Carolina.
Top News
IWB_CFD
+1.29%
UMB_Financial
+3.00%
Glaukos
+2.62%
Ocugen
+9.59%
Veritone
+5.77%
Accendra.Health
+4.35%
AREC
-1.72%
Anavex
+6.03%
Eyepoint.Pharmaceuticals
+5.71%
Heron
+0.00%
Invivyd
+9.26%
Karyopharm
-14.29%
Optimum.Communication
+17.24%
Oscar.Health
+6.52%
PLBY_Group
+6.98%
Wheelsup
+1.28%
Voyager.Therapeutics
+7.56%
Russell 2000 estimated to drop 83 stocks in December rebalance - Stephens
tradingview.com
5d ago
Heron
+0.00%
Heron Therapeutics to Report Third Quarter 2026 Financial Results on Monday, November 9, 2026
tradingview.com
1w ago
Heron
+0.00%
Heron Therapeutics Inks Multi-Product U.S. License With Long Grove, 10-Year Term Plus Renewals
tradingview.com
1mo ago
Show more
Frequently Asked Questions
What are healthcare stocks and why are they important to investors?
Healthcare stocks include pharmaceutical companies, biotech firms, hospitals, and medical device manufacturers.
Are healthcare stocks less volatile?
Generally yes. Because healthcare is a necessity, demand remains relatively steady, making the sector less sensitive to economic cycles.
What drives growth in healthcare investments?
Aging populations, technological advancements, and increased healthcare spending contribute to long-term growth in the sector.
What are the risks of investing in healthcare?
Regulatory changes, drug approval delays, and legal challenges can affect the profitability and stock prices of healthcare companies.
